Abstract
By focusing on the studies of primate behaviour and human neuroscience, we describe how different neurological processes are the base of proximate aspects of social-decision making. We also review the fact that distinct aspects of animal behaviour are not under conscious or abstract control and that instead they may be regulated by adaptive ´rules of thumb´. In particular, by describing the microbiota- gut-brain axis we elaborate on suggesting that microbiota has an influence on within-individual aspects of social decision making and in particular facilitating social interactions. Finally, we present comparative evidence of the role of microorganisms as modifiers of aspects of kinship, reproduction and group-members´ recognition, suggesting how microbiota also has an influence on betweenindividual aspects of decision making, which are themselves primary aspects of cooperation. In summary, we propose that modern socioeconomic choice theories may still benefit from alternative theoretical frameworks that consider the human being as a complex organism, with intrinsic constraints and capacities product of its evolutionary history, and not just as an exclusively-cognitive decision maker acting independently of its closest partners and commensals: its microbiota.
Keywords: Neuroeconomics, microbiota, probiotics, decision making process, social neurosciences.
Current Pharmaceutical Design
Title:Social Neuroeconomics: The Influence of Microbiota in Partner-Choice and Sociality
Volume: 20 Issue: 29
Author(s): Montiel-Castro, Augusto J., Baez-Yanez, Mario G. and Pacheco-Lopez Gustavo
Affiliation:
Keywords: Neuroeconomics, microbiota, probiotics, decision making process, social neurosciences.
Abstract: By focusing on the studies of primate behaviour and human neuroscience, we describe how different neurological processes are the base of proximate aspects of social-decision making. We also review the fact that distinct aspects of animal behaviour are not under conscious or abstract control and that instead they may be regulated by adaptive ´rules of thumb´. In particular, by describing the microbiota- gut-brain axis we elaborate on suggesting that microbiota has an influence on within-individual aspects of social decision making and in particular facilitating social interactions. Finally, we present comparative evidence of the role of microorganisms as modifiers of aspects of kinship, reproduction and group-members´ recognition, suggesting how microbiota also has an influence on betweenindividual aspects of decision making, which are themselves primary aspects of cooperation. In summary, we propose that modern socioeconomic choice theories may still benefit from alternative theoretical frameworks that consider the human being as a complex organism, with intrinsic constraints and capacities product of its evolutionary history, and not just as an exclusively-cognitive decision maker acting independently of its closest partners and commensals: its microbiota.
Export Options
About this article
Cite this article as:
Montiel-Castro , J. Augusto, Baez-Yanez , G. Mario and Gustavo Pacheco-Lopez, Social Neuroeconomics: The Influence of Microbiota in Partner-Choice and Sociality, Current Pharmaceutical Design 2014; 20 (29) . https://dx.doi.org/10.2174/1381612820666140130210631
DOI https://dx.doi.org/10.2174/1381612820666140130210631 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cell-Permeable Peptide Inhibitor of c-Jun NH2-Terminal Kinase for the Treatment of Diabetes
Current Bioactive Compounds Autism: Pathophysiology and Promising Herbal Remedies
Current Pharmaceutical Design Tactile Angle Discrimination Decreases due to Subjective Cognitive Decline in Alzheimer’s Disease
Current Alzheimer Research Microglial Activation as a Compelling Target for Treating Acute Traumatic Brain Injury
Current Medicinal Chemistry Oxidative Stress and Cancer: The Role of Nrf2
Current Cancer Drug Targets Dopamine Neurotransmission and Atypical Antipsychotics in Prefrontal Cortex: A Critical Review
Current Topics in Medicinal Chemistry Histamine H<sub>4</sub> Receptor Antagonists: A New Approach for Tinnitus Treatment?
Recent Patents on CNS Drug Discovery (Discontinued) Tetracyclines and Neuromuscular Disorders
Current Neuropharmacology Adenosine A2A Receptors in Psychopharmacology: Modulators of Behavior, Mood and Cognition
Current Neuropharmacology Cognitive Impairment and Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Protective Effects of Corticosteroids and Neurosteroids on Cochlear injury
Medicinal Chemistry New Insights into the Pathogenesis of Fibromyalgia Syndrome: Important Role of Peripheral and Central Pain Mechanisms
Current Rheumatology Reviews Diagnostic Cardiac Catheterization in the Pediatric Population
Current Cardiology Reviews Stimulating Effects of H1-Antagonists
Current Pharmaceutical Design Update on the Slow Delayed Rectifier Potassium Current (IKs): Role in Modulating Cardiac Function
Current Medicinal Chemistry Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists
Current Pharmaceutical Design Nature and Nurture: Genetic Influences and Gene-Environment Interactions in Depression
Current Psychiatry Reviews Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part I: Principles of Functional Organisation
Current Neuropharmacology STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery Aminoglycoside-Induced Ototoxicity
Current Pharmaceutical Design